Role of surgical management in invasive mole: a report of 2 cases and review of literature

Kavita Khoiwal; Kripa Yadav; Kanhu C. Dash; Arvind Kumar; Jaya Chaturvedi

doi:10.18203/2320-1770.ijrcog20230149

Authors

Kavita Khoiwal Department of Obstetrics and Gynecology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India
Kripa Yadav Department of Obstetrics and Gynecology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India
Kanhu C. Dash Department of Obstetrics and Gynecology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India
Arvind Kumar Department of Pathology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India
Jaya Chaturvedi Department of Obstetrics and Gynecology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20230149

Keywords:

Surgical management, Beta hCG, Hysterectomy, Chemotherapy , Invasive mole

Abstract

Invasive mole is a rare gestational trophoblastic neoplasia with proliferative trophoblast invading into myometrium or uterine vasculature. Primary management of invasive mole is chemotherapy, but hysterectomy can be performed in selective cases. In this report, we discuss two cases of invasive mole, which required surgical intervention in the form of a hysterectomy. Both patients had a favorable outcome and are in remission.

Metrics

Metrics Loading ...

References

Von welser SF, Grube M, Ortmann O. Invasive mole in a perimenopausal woman. A case report and systematic review. Arch Gynecol Obstet. 2015;292:1193-9.

Lurain JR. Gestational trophoblastic disease: Epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol. 2010;203(6):531-9.

Aymen FM, Slim K, Khaled N. Uterine rupture and shock: An unusual presentation of gestational trophoblastic neoplasm. Am J Obstet Gynecol. 2021;225(2):191.

Mamede R, Beja M, Djokovic D, Costa C. Invasive mole presenting as a heavily bleeding vaginal lesion 3 weeks after uterine evacuation. BMJ Case Rep. 2021;14(6):e242208.

Harsono AB, Hidayat YM, Winarno GNA, Nisa AS, Alkaff FF. A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG Serum Levels in Follow-Up Evaluation. Am J Case Rep. 2021;22:e931156

Singhal S, Kumar L, Kumar S, Khurana S, Bhatla N. Predictors of chemotherapy resistance & relapse in gestational trophoblastic neoplasia: Indian J Med Res. 2020;152(6):595-606.

Feng FZ, Xiang Y, Wan XR, Yin SJ, Yang XY. Clinical characteristics and management of gestational trophoblastic disease in women aged 50 years or more. Zhonghua Fu Chan Ke Za Zhi. 2005;40(9):605-8.

Pires LV, Uberti EM, Fajardo MDC, Cunha AGV, Rosa MW, Ayub ACK, et al. Role of hysterectomy in the management of patients with gestational trophoblastic neoplasia: importance of receiving treatment in reference centers. J Reprod Med. 2012;57(7-8):359-68.

Alazzam M, Hancock BW, Tidy J. Role of hysterectomy in managing persistent gestational trophoblastic disease. J Reprod Med. 2008;53(7):519-24.

Cagayan MS, Magallanes MS. The role of adjuvant surgery in the management of gestational trophoblastic neoplasia. J Reprod Med. 2008;53(7):513-8.

Clark RM, Nevadunsky NS, Ghosh S, Goldstein DP, Berkowitz RS. The evolving role of hysterectomy in gestational trophoblastic neoplasia at the New England Trophoblastic Disease Center. J Reprod Med. 2010;55(5-6):194-8.